Immunomedics, Inc. (IMMU) Trumps Q2 EPS, Revenue Views
Tweet
Share
E-mailGet Alerts IMMU Hot Sheet
Price: $87.86 --0%
Financial Fact:
General and administrative: 691.58K
Today's EPS Names:
EDXC, BICX, FBPI, More
Financial Fact:
General and administrative: 691.58K
Today's EPS Names:
EDXC, BICX, FBPI, More
Join SI Premium – FREE
Immunomedics, Inc. (NASDAQ: IMMU) reported Q2 EPS of $0.27, $0.35 better than the analyst estimate of ($0.08). Revenue for the quarter came in at $29.7 million versus the consensus estimate of $11.47 million.
For earnings history and earnings-related data on Immunomedics, Inc. (IMMU) click here.
For earnings history and earnings-related data on Immunomedics, Inc. (IMMU) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Etsy upgraded to buy at BofA on durable growth, buyback potential
- Walmart (WMT) Tops Q2 EPS by 7c, Beats on Revenue; Offers FY27 EPS Guidance
- Holcim to acquire Fermacell from James Hardie for EUR 840M
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
